Yingnan Zeng
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Depression of CaV1.2 activation and expression in mast cells ameliorates allergic inflammation diseases.
Journal: Journal of pharmaceutical analysis
Published: August 15, 2024
Licochalcone A inhibits MAS-related GPR family member X2-induced pseudo-allergic reaction by suppressing nuclear migration of nuclear factor-κB.
Journal: Phytotherapy research : PTR
Published: April 25, 2021
Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway.
Journal: Biochemical pharmacology
Published: November 05, 2020
Discovery and analysis the anti-pseudo-allergic components from Perilla frutescens leaves by overexpressed MRGPRX2 cell membrane chromatography coupled with HPLC-ESI-IT-TOF system.
Journal: The Journal of pharmacy and pharmacology
Published: December 23, 2019
Baicalin induces Mrgprb2-dependent pseudo-allergy in mice.
Journal: Immunology letters
Published: October 28, 2019
Isoimperatorin reduces the effective dose of dexamethasone in a murine model of asthma by inhibiting mast cell activation.
Journal: Phytotherapy research : PTR
Published: September 18, 2019
Gold induces a pseudo-allergic reaction via MRGPRX2 both in vitro and in vivo.
Journal: Cellular immunology
Published: December 29, 2018
Dehydroandrographolide inhibits IgE-mediated anaphylactic reactions via calcium signaling pathway.
Journal: Toxicology and applied pharmacology
Published: October 20, 2018
The anti-inflammation effect of Baige capsule and its principal components mixture in MCAO rats.
Journal: Immunopharmacology and immunotoxicology
Published: June 27, 2018
Anti-pseudo-allergy effect of isoliquiritigenin is MRGPRX2-dependent.
Journal: Immunology letters
Published: February 14, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026